Nadi Tarangini – India’s First Ayurvedic Diagnostic Device Approved by CDSCO

On January 6, 2025, Nadi Tarangini, an AI-powered pulse diagnostic device developed by Atreya Innovations, received approval from the Central Drugs Standard Control Organization (CDSCO), making it India’s first ayurvedic medical device to be officially recognized. The device, which combines modern technology with ancient Ayurvedic practices, was created after over six years of research, and aims to revolutionize traditional Ayurvedic diagnostic methods by offering precise health insights through pulse examination.

Overview of Nadi Tarangini

First Ayurvedic Diagnostic Service

• India’s first ayurvedic medical device to receive CDSCO approval.
• Developed to speed up traditional Ayurvedic practices using AI-powered technology.
• Price: ₹55,000
• Manufacturer: Atreya Innovations, based in Hinjewadi, Pune.

Development and Research

Brainchild

• Conceived by Padma Bhushan awardee Prof. J.B. Joshi and Dr. Aniruddha Joshi after over six years of research at IIT Bombay.
• Research initiated due to a personal health issue faced by Prof. J.B. Joshi, which highlighted the importance of pulse examination in Ayurveda.

Key Technology

• Uses piezoelectric pressure sensors to mimic the tactile sensation of pulse examination.
• Developed after testing multiple sensors to create a device that delivers accurate pulse readings.

Funding and Manufacturing Capacity

• Seed funding of ₹5 crore received to expand research and production capacity.
• Production capacity: 5,000 devices per year.

Functionality of Nadi Tarangini

Diagnostic Features

• The device analyzes 22 Ayurvedic parameters, including Tridosha balance (Vata, Pitta, Kapha), stress levels, digestive health, and overall well-being.
• Produces a 10-page report with detailed health insights based on pulse data.
• Report available in 10 Indian languages.
• Accuracy of the device is approximately 85%.

Use in Ayurveda

• Primarily used in over 1250 Ayurvedic clinics across India.
• More than 5 lakh individuals have been tested using the device.

Recognition and Patents

• US Patent awarded for the sensing technology and process.
• Patents also granted in Europe, Indonesia, and India.

Government and Public Reaction

• Mentioned by Prime Minister Narendra Modi in his Mann Ki Baat program, praising the device’s contribution to Ayurveda and technology integration.

Impact and Future Directions

Standardization of Ayurveda

• Nadi Tarangini is seen as a step towards standardizing Ayurvedic practices through the use of modern technology.
• It marks the beginning of integrating technology into traditional medicine, making it globally accessible.

Expansion Plans

• The company plans to increase its production and expand distribution to make the device widely available across the globe.

Summary/Static	Details
Why in the news?	Nadi Tarangini – India’s First Ayurvedic Diagnostic Device Approved by CDSCO
Approval Authority	Central Drugs Standard Control Organization (CDSCO)
Price	₹55,000
Manufacturer	Atreya Innovations, Hinjewadi, Pune
Development Period	Over six years of research at IIT Bombay
Key Technology	AI-powered pulse diagnostic device using piezoelectric sensors
Functionality	Analyzes 22 Ayurvedic parameters, including Tridosha balance
Accuracy	Approximately 85%
Reports	10-page reports, available in 10 Indian languages
Patents	US, Europe, Indonesia, India
Use in Clinics	Over 1250 Ayurvedic clinics across India
Total Tests Conducted	More than 5 lakh individuals tested
Seed Funding	₹5 crore for research and expansion
International Recognition	Praised by PM Narendra Modi in Mann Ki Baat program
Future Plans	Expand production capacity and distribution network